Efficacy vs. effectiveness: erlotinib in previously treated non-small-cell lung cancer
N Sheikh, CR Chambers - Journal of Oncology Pharmacy …, 2013 - journals.sagepub.com
Background: A randomized trial carried out by Shepherd et al. in patients with advanced or
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
Efficacy vs. effectiveness: erlotinib in previously treated non-small-cell lung cancer
N Sheikh, CR Chambers - 2013 - pubmed.ncbi.nlm.nih.gov
Background A randomized trial carried out by Shepherd et al. in patients with advanced or
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
Efficacy vs. effectiveness: erlotinib in previously treated non-small-cell lung cancer.
N Sheikh, CR Chambers - … Publication of the International Society of …, 2012 - europepmc.org
Background A randomized trial carried out by Shepherd et al. in patients with advanced or
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
[PDF][PDF] Efficacy vs. effectiveness: Erlotinib in previously treated non-small-cell lung cancer
N Sheikh, CR Chambers - Citeseer
Background: A randomized trial carried out by Shepherd et al. in patients with advanced or
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
Efficacy vs. effectiveness: Erlotinib in previously treated non-small-cell lung cancer.
N Sheikh, CR Chambers - Journal of Oncology Pharmacy …, 2013 - search.ebscohost.com
Background: A randomized trial carried out by Shepherd et al. in patients with advanced or
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
Efficacy vs. effectiveness: Erlotinib in previously treated non-small-cell lung cancer
N Sheikh, CR Chambers - Journal of Oncology Pharmacy …, 2013 - search.proquest.com
Background: A randomized trial carried out by Shepherd et al. in patients with advanced or
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
[PDF][PDF] Efficacy vs. effectiveness: Erlotinib in previously treated non-small-cell lung cancer
N Sheikh, CR Chambers - Citeseer
Background: A randomized trial carried out by Shepherd et al. in patients with advanced or
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …
metastatic non-small-cell lung cancer showed statistically significant benefit of erlotinib over …